⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FTRE News
Fortrea Holdings Inc. Common Stock
Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development
businesswire.com
FTRE
Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development
businesswire.com
FTRE
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
globenewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Investors to Inquire about Securities Investigation
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Reach Out
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Reach Out
accessnewswire.com
FTRE
From FIH to POC -- Designing Phase I/Ib Trials with Efficiency, Upcoming Webinar Hosted by Xtalks
prnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect
accessnewswire.com
FTRE